article thumbnail

Access solutions: the missing link that prevents biopharma innovation from reaching patients

pharmaphorum

However, most models are based on an old-fashioned and expensive call centre-based approach that fails to meet the needs of patients and healthcare providers (HCPs) as consumers. The post Access solutions: the missing link that prevents biopharma innovation from reaching patients appeared first on.

article thumbnail

AmerisourceBergen introduces CGT integration hub

Pharmaceutical Technology

Powered by the company’s customer relationship management system, the CGT integration hub is a platform-agnostic system that aims to improve connectivity across the CGT treatment journey, enhancing the experience for patients and healthcare providers.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Challenging State Abortion Bans in Light of FDA’s Rule Change on the Sale of Abortion Pills

MedCity News

The current legal landscape makes access to medication abortion crucial in protecting as much access to reproductive healthcare as possible and in protecting healthcare providers’ abilities to do their jobs without fear of prosecution.

article thumbnail

Navigating the rapidly changing oncology treatment landscape: how digital tools can help

Impetus Digital

Emerging biopharma companies are responsible for over 70% of these products (up 20 percentage points from 2017) while Big Pharma has seen a declining share of the oncology pipeline, at only around 20% of products currently under development (down 15 percentage points from 2017).

article thumbnail

Fireside Chat with Dr. Ittai Dayan, Co-founder & CEO at Rhino Health

Impetus Digital

Ittai Dayan , Co-founder & CEO of Rhino Health , will join Natalie Yeadon , Co-founder & CEO of Impetus Digital , to share how his company is transforming the way healthcare AI solutions are created, adopted and measured. Register now! Register for this free webinar. Book a Consultative Demo.

article thumbnail

Veradigm® Digital Health Media Works to Message the Right Physicians at the Right Time

PM360

Though 80% of healthcare providers (HCPs) identified as “rep-accessible” in 2008 (that is, willing to meet with over 70% of the sales reps who try to approach them), that number had decreased to 44% in 2017. No biopharma or device advertisements appear during the prescribing workflow.

article thumbnail

HCP Engagement & Education

PM360

With an ever- increasing demand for their time and attention, it is more difficult than ever for biopharma representatives to convey their message to the physician audience. In one survey, only 12% of HCPs said they felt biopharma companies are very effective at providing HCP education and training to them.